2.65

0.00% 0.00

Silo Pharma Inc (SILO)

Overview News Price History Financials Discussions Forecast Stock Split

Silo Pharma Inc stock is traded at $2.65, with a volume of 34,491. It is up +0.00% in the last 24 hours and down -40.72% over the past month. SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Previous Close:

$2.65

Open:

$2.64

24h Volume:

34,491

Relative Volume:

0.19

Market Cap:

$4.11M

Revenue:

$72,100

Net Income/Loss:

$-4.84M

P/E Ratio:

-0.3554

EPS:

-7.4566

Net Cash Flow:

$-3.84M

1W Performance:

-13.68%

1M Performance:

-40.72%

6M Performance:

-49.34%

1Y Performance:

-72.00%

1-Day Range:

$2.501

$2.732

1-Week Range:

$2.501

$3.30

52-Week Range:

$2.501

$15.15

Silo Pharma Inc Stock (SILO) Company Profile

Name

Silo Pharma Inc

Sector

Healthcare (1087)

Industry

Biotechnology (604)

Phone

(718) 400-9031

Address

677 N. WASHINGTON BLVD, SARASOTA

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

SILO's Discussions on Twitter

Compare SILO vs MOBBW, PSNYW, GOODO, SHMD, DWLD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SILO SILO PHARMA INC	1.71	17.96M	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	2.32	3.04B	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	2.69	394.14M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	21.06	372.90M	0	0	0	0.00
SHMD Schmid Group N V	4.82	315.90M	52.15M	-21.46M	0	-0.4675
DWLD Davis Select Worldwide ETF	47.87	0	0	0	0	0.00

Silo Pharma Inc Stock (SILO) Latest News

Aug 20, 2026

Form 8K Silo Pharma Inc For: 19 August By Investing.com - Investing.com South Africa

Aug 20, 2026

Aug 19, 2026

Silo Pharma Acquires Digital Assets via Stock Issuance - TipRanks

Aug 19, 2026

Silo Pharma Acquires Software and IP From Parkview Consulting for 165,000 Shares - TradingView

Aug 19, 2026

Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting - TradingView

Aug 19, 2026

Silo Pharma Secures Canadian Patent Allowance for PTSD Treatment SPC-15 - citybuzz -

Aug 19, 2026

Aug 18, 2026

Silo Pharma receives Canadian patent allowance for SPC-15 drug By Investing.com - Investing.com Canada

Aug 18, 2026

Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - The Manila Times

Aug 18, 2026

A PTSD treatment designed to build stress resilience gets Canadian patent allowance - Stock Titan

Aug 18, 2026

Silo (SILO) Technical Check: Adds 1.95% to Close at $3.13; Range and Risk: the $2.97 to $3.29 Range Remains in Focus in the Current UpdateSuperTrend - Vinanet

Aug 18, 2026

Aug 17, 2026

Silo Pharma Shareholders Approve Major Share Authorization Expansion - TipRanks

Aug 17, 2026

Silo Pharma (SILO) holders approve lifting share cap from 6.7M - Stock Titan

Aug 17, 2026

Aug 15, 2026

Silo Pharma (SILO) Slips 0.62% to $3.20 as Shares Consolidate Between Key Technical LevelsStock Picks - Vinanet

Aug 15, 2026

Aug 13, 2026

Silo Pharma (SILO) trims cash burn, mitigates going-concern risk in Q2 2026 - Stock Titan

Aug 13, 2026

Silo Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap - Stock Titan

Aug 13, 2026

Aug 10, 2026

Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com South Africa

Aug 10, 2026

Silo Pharma Granted European Patent Covering Novel PTSD Therapy - The Manila Times

Aug 10, 2026

Silo Pharma receives European patent for SPC-15 PTSD treatment - Investing.com India

Aug 10, 2026

Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - Quiver Quantitative

Aug 10, 2026

SILO Q4 2023 Earnings: EPS Misses Estimates, Stock Gains 1.2% Despite No RevenueCore Business Growth - vinanet.vn

Aug 10, 2026

Aug 07, 2026